In spite of the heterogeneity of mutations that result in multiple cancer types, and the consequent diversity of the underlying mechanisms by which 2DG and TRAIL could interact to induce apoptosis, this combination therapy was successful in multiple gastrointestinal cancer cell lines and did not affect normal cells. The gene discussed is TNFSF10; the disease is cancer.